Treatment of aggressive non-Hodgkins lymphoma with anti-CD20 antibody

CAFC
  • US 8,557,244 B1
  • Filed: 07/28/2000
  • Issued: 10/15/2013
  • Est. Priority Date: 08/11/1999
  • Status: Expired due to Term
First Claim
Patent Images

1. A method of treating a patient with diffuse large cell lymphoma, comprising administering an unlabeled chimeric anti-CD20 antibody and CHOP (cyclophosphamide, hydroxydaunorubicin/doxorubicin, vincristine, and prednisone/prednisolone) chemotherapy to the patient, wherein the patient is >

  • 60 years old and has bulky disease (tumor >

    10 cm in diameter).

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×